For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
Source: Thailand Medical News  Nov 14, 2019  5 years, 1 week, 22 hours, 11 minutes ago

Inhibiting Newly Discovered Molecule Can Slow Multiple Sclerosis Progression

Inhibiting Newly Discovered Molecule Can Slow Multiple Sclerosis Progression
Source: Thailand Medical News  Nov 14, 2019  5 years, 1 week, 22 hours, 11 minutes ago
Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have identified a molecule named ALCAM (Activated Leukocyte Cell Adhesion Molecule), which, once blocked, delays the progression of the multiple sclerosis.



More than 4.8 million people live with multiple sclerosis globally, with about 300 new cases being diagnosed per week in the US and about 440 per week in Canada. Sixty per cent of adults with multiple sclerosis are between the ages of 20 and 49 and women are three times more likely than men to be diagnosed with it.

Multiple sclerosis, a disease whose causes still remain unknown and presently there is no cure. Scientists believe that a combination of environmental and genetic factors contribute to the risk of developing MS. 

In a new study published in Science Translational Medicine, the findings of the new study obtained from in vitro human and in vivo mouse studies, could lead to the development of a new generation of therapies to treat this autoimmune disease.

In normal conditions, the blood-brain barrier protects our brain from exposure to harmful elements. For example, it prevents cells of the immune system such as lymphocytes from invading our central nervous system.

However, in people with multiple sclerosis, this barrier is permeable. A large number of lymphocytes manage to migrate into the brain and deteriorate its tissues (by destruction of the myelin sheath that protects the neurons and enables the transmission of nerve impulses).

Dr. Alexandre Prat, a researcher at the CRCHUM, professor at the Université de Montréal and holder of the Canada Research Chair in Multiple Sclerosis told Thailand Medical News via a phone interview, "In our study, we show for the first time that a molecule called ALCAM (Activated Leukocyte Cell Adhesion Molecule), expressed by B cells, controls their entry into the brain via blood vessels. It allows them to migrate to the other side of the blood-brain barrier in mice and humans. By blocking this molecule in mice, we were able to reduce the flow of B cells into their brains and, as a result, slow the progression of the disease."

Typically, B cells contribute to the progressive phase of multiple sclerosis. Certain medications, commonly known as anti-B-cell drugs, reduce its progression and the resulting disability.

Dr. Prat further added, "The molecule ALCAM is expressed at higher levels on the B cells of people with multiple sclerosis. By specifically targeting this molecule, we will now be able to explore other therapeutic avenues for the treatment of this disease.”

Generally, multiple sclerosis can cause symptoms such as fatigue, lack of coordination, vision problems, cognitive impairment and mood changes.

It has also been observed that the number of people developing multiple sclerosis have more than doubled over the last 4 years ie since 2015. Some attribute this to dietary habits and the increased consumption of studies-proving-that-ultra-processed-foods-are-a-health-risks">ultra-processed foods that can cause epigenetic effects.
 
Reference: L. Michel el al., "Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers," Science Translational Medicine (2019). stm.sciencemag.org/lookup/doi/ … scitranslmed.aaw0475
 

MOST READ

Nov 05, 2024  17 days ago
Nikhil Prasad
Jul 25, 2024  4 months ago
Nikhil Prasad
Jul 24, 2024  4 months ago
Nikhil Prasad
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer